Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
Journal of Clinical Medicine · 03.01.2023 · 12 (1) · 390
DOI: 10.3390/jcm12010390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.01.2023. Verfasst von Maurizio Nordio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University "Sapienza", 00161 Rome, Italy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recent studies reported possible concerns following long-lasting treatments with high doses of D-chiro-inositol in women. However, to date, no clinical trial has investigated or validated these concerns. We addressed this issue both retrospectively and with a prospective pilot study.
Methods
For the retrospective analysis, we searched our databases for insulin-resistant women who took 1200 mg/day D-chiro-inositol for 6 months. In our prospective study, we enrolled 10 healthy women to supplement with the same therapeutic scheme. We performed statistical analyses through the Wilcoxon Signed-Rank Test. A p-value < 0.05 was considered significant.
Results
Twenty women underwent 6 months of 1200 mg/day D-chiro-inositol. The treatment significantly decreased BMI, glycemia, insulinemia, HOMA-IR, serum levels of LH, total testosterone, and DHEAS. Serum estradiol rose and menstrual abnormalities occurred following the treatment. In our prospective study, we observed increases in serum levels of total testosterone and asprosin in healthy women.
Conclusions
This is the first clinical evidence demonstrating that long-term treatments with high dosages of D-chiro-inositol can predispose women to hormonal and menstrual abnormalities. Moreover, the accumulation of D-chiro-inositol following such treatment regimen may lead to detrimental effects in non-reproductive tissues, as demonstrated by the increase in asprosin levels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Medicine, University "Sapienza", 00161 Rome, Italy.
- The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00156 Rome, Italy.
- Systems Biology Group Lab, 00161 Rome, Italy.
- Alma Res Fertility Center, 00198 Rome, Italy.
- Department of Obstetrics and Gynecology, Santo Spirito Hospital, 00193 Rome, Italy.
ORCID-Profile: Mario Montanino Oliva
Zitieren
APA
Nordio, M., Bezerra Espinola, M. S., Bilotta, G., Capoccia, E., & Montanino Oliva, M. (2023). Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside. Journal of Clinical Medicine, 12(1), 390. https://doi.org/10.3390/jcm12010390
Vancouver
Nordio M, Bezerra Espinola MS, Bilotta G, Capoccia E, Montanino Oliva M. Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside. Journal of Clinical Medicine. 2023;12(1):390. doi:10.3390/jcm12010390
BibTeX
@article{Nordio2023,
author = {Nordio, Maurizio and Bezerra Espinola, Maria Salomè and Bilotta, Gabriele and Capoccia, Elena and Montanino Oliva, Mario},
title = {Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {1},
pages = {390},
doi = {10.3390/jcm12010390}
}
EUVIMED